Opendata, web and dolomites

PI3K-in-tolerance SIGNED

PI3K delta role in dendritic cell antigen processing and presentation to control gut tolerance

Total Cost €


EC-Contrib. €






 PI3K-in-tolerance project word cloud

Explore the words cloud of the PI3K-in-tolerance project. It provides you a very rough idea of what is the project "PI3K-in-tolerance" about.

commensal    opportunistic    pi3k    presentation    model    activation    gene    phagosome    nox2    antigens    recognition    environmental    shows    preliminary    presented    vesicles    nod2    first    pathogens    omvs    membrane    reactive    signaling    engagement    defects    senses    tolerance    intestinal    mice    cgd    il10    cd4    prrs    data    muramyl    pathology    spontaneously    inactivated    gut    resistance    activate    controls    mhcii    inducing    mechanisms    delta    rac2    disease    subunits    oxygen    adaptive    nadph    bridge    ros    kinase    innate    treg    encoding    homeostasis    cell    bacteria    domain    mediating    vesicular    fragilis    genes    mutations    chronic    receptors    sites    phagosomal    pi3ks    dysregulated    colitis    released    biological    gtpase    animal    functions    interactions    granulomatous    mucosal    intrinsic    oxidase    cd    immunity    signalling    induce    originating    crohn    species    antigen    tregs    family    patients    shown    dipeptide    prr    bacteriodes    pathogen    microbiome    app    concurrently    critical    dcs    susceptibility    microbiota    vitro    events    triggered    outer    documented    stimulate    maintaining    trafficking    linked    dc    activated   

Project "PI3K-in-tolerance" data sheet

The following table provides information about the project.


Organization address
address: 327 MILE END ROAD
city: LONDON
postcode: E1 4NS

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 212˙933 €
 EC max contribution 212˙933 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    QUEEN MARY UNIVERSITY OF LONDON UK (LONDON) coordinator 212˙933.00


 Project objective

PI3Ks controls important biological processes immunity controlling vesicular trafficking and cell signaling events triggered by pathogen recognition receptors (PRRs). The engagement of PRRs leading to DC antigen processing and presentation (APP) is essential for the bridge between innate and adaptive immunity. Thus, DCs are crucial for resistance against pathogens, while concurrently maintaining tolerance to the commensal microbiota and environmental antigens. Crohn’s disease (CD)-like pathology has been documented in patients with chronic granulomatous disease (CGD), originating from mutations in genes encoding NADPH oxidase (NOX2) subunits or RAC2 GTPase. Both PRR-activated NOX2 and RAC2 are critical for inducing phagosomal reactive oxygen species (ROS) linked to APP processes in the DC. Thus, that dysregulated PRR signalling and NOX2 activity in the DC phagosome, may be key steps involved in some of the pathology observed in CD. The PRR family member NOD2 senses muramyl dipeptide in bacteria. NOD2 was the first susceptibility gene identified for CD and associated with tolerance mechanisms mediating intestinal homeostasis to gut microbiota. Recently, interactions between NOD2 and microbiome were shown to stimulate Treg activity at the mucosal sites. Bacteria-derived outer membrane vesicles (OMVs) from gut commensal Bacteriodes fragilis induce mucosal tolerance by DC-intrinsic activation of NOD2 and enabling DCs to induce IL10 production from Tregs. It is known that OMVs require NOX2-induced ROS to be released for APP and presented by MHCII to activate CD4 Tregs. Our preliminary data shows that mice inactivated in the kinase domain of PI3K delta spontaneously develop colitis in the presence of an intestinal opportunistic pathogens and show defects in antigen presentation in DCs in vitro. Based on these results, I propose to investigate the DC-intrinsic PI3K role in APP functions that control gut tolerance in this animal model of colitis.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PI3K-IN-TOLERANCE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PI3K-IN-TOLERANCE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

SCAPA (2019)

Functional analysis of Alternative Polyadenylation during neuronal differentiation at single cell resolution

Read More  

Extending MEDT (2019)

Extending the Molecular Electron Density Theory

Read More  

ProTeCT (2019)

Proteasome as a target to combat trichomoniasis

Read More